REG - Sinclair IS Pharma - Director/PDMR Shareholding <Origin Href="QuoteRef">CHLL.L</Origin> <Origin Href="QuoteRef">SPH.L</Origin>

Cloudified HoldingsAnnouncement

29/10/2014 12:06

RNS Number : 5071U
Sinclair IS Pharma PLC
16 October 2014
16 October 2014
Directors' Dealings - Replacement
The following amendment has been made to the Directors' Dealings announcement released on 15 October 2014 at 07:30 am under RNS No 3213U
The date of the share purchase by Christophe Foucher was 10 October 2014 not 14 October 2014.
Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 14 October 2014 that earlier that day Julie Spooner, spouse of Chris Spooner, the Chief Executive Officer, acquired 238,430 ordinary shares in Sinclair. The purchases were made at an average price of 26.25p per share. Following this purchase Chris Spooner has a beneficial interest in 8,989,164 ordinary shares representing 1.81% of the Group's issued ordinary share capital.
Sinclair was also informed on 10 October 2014 that earlier that day Christophe Foucher, the Chief Operating Officer, acquired 35,000 ordinary shares in Sinclair at an average price of 24.25p per share.Following this purchase Christophe Foucher has a beneficial interest in 191,200 ordinary shares representing 0.04% of the Group's issued ordinary share capital.
For further information, please contact:
Sinclair IS Pharma plc 
Tel: +44 (0) 20 7467 6920
Chris Spooner
Alan Olby
Peel Hunt LLP 
Tel: +44 (0) 20 7418 8900
James Steel
Clare Terlouw

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSGGGMAUUPCGGQ